Shore Capital began coverage on shares of Blackrock Health Sciences Trust (NYSE:BME) in a research report report published on Friday morning, Stock Target Advisor reports. The brokerage issued a buy rating and a $429.00 price objective on the stock.
BME traded up $0.02 on Friday, reaching $39.13. The stock had a trading volume of 20,409 shares, compared to its average volume of 31,259. Blackrock Health Sciences Trust has a fifty-two week low of $32.00 and a fifty-two week high of $42.49. The firm has a 50-day moving average of $38.28 and a 200-day moving average of $38.12.
The company also recently announced a monthly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a $2.40 dividend on an annualized basis and a yield of 6.13%.
Blackrock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.